Download PDF
Horm Metab Res 2012; 44(03): 215-220
DOI: 10.1055/s-0031-1299730
Humans, Clinical
© Georg Thieme Verlag KG Stuttgart · New York

The Prevalence of Familial Hyperaldosteronism in Apparently Sporadic Primary Aldosteronism in Germany: a Single Center Experience

A. Pallauf
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
,
C. Schirpenbach
2   Medizinische Klinik I, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Würzburg, Germany
,
O. Zwermann
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
,
E. Fischer
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
,
M. Morak
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
3   Medical Genetic Center Munich, Munich, Germany
,
E. Holinski-Feder
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
3   Medical Genetic Center Munich, Munich, Germany
,
L. Hofbauer
4   Medizinische Klinik III, Universitätsklinikum der Technischen Universität Gustav-Carus, Dresden, Germany
,
F. Beuschlein
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
,
M. Reincke
1   Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany
› Author Affiliations
Further Information

Publication History

received 10 October 2011

accepted 13 December 2011

Publication Date:
24 January 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension. To date 3 forms of familial hyperaldosteronism (FH) have been described accounting for a small percentage of all PA cases. In Germany, the prevalence of FH is currently unknown. Our aim was to determine the prevalence of familiarity in a large cohort of patients with PA. A total of 166 patients with apparently sporadic PA in Munich were investigated. FH types I, II, and III were identified using established clinical, biochemical, and molecular criteria. Among the 166 patients with PA, 2 patients (1.2%) reported a family history suggestive of FH. None of the 166 patients showed clinical, endocrine, or genetic evidence of FH type I. The 2 families had characteristic features of FH type II. Family A had 3 subjects affected out of 11 evaluated family members. Family B had 3 out of 4. Bilateral adrenal hyperplasia and unilateral adrenal adenoma were found within the same family. FH type I and FH type III are rare in Germany. With a prevalence of 1.2%, FH type II seems to be more common in apparently sporadic PA than had been assumed so far.

Key words

conn syndrome - primary aldosteronism - genetics - CYP11B1/CYP11B2
 

  • References

  • 1 Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966; 95: 1109-1119
    Google Scholar
  • 2 Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355 (6357) 262-265
    Google Scholar
  • 3 Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B, Gordon RD, Duffy D, Stowasser M. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin Exp Pharmacol Physiol 2008; 35 (04) 380-385
    CrossrefPubMedGoogle Scholar
  • 4 So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 2005; 23 (08) 1477-1484
    Google Scholar
  • 5 Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 2008; 93 (08) 3117-3123
    Google Scholar
  • 6 Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331 (6018) 768-772
    Google Scholar
  • 7 Quack I, Vonend O, Rump LC. Familial hyperaldosteronism I-III. Horm Metab. Res 2010; 42 (08) 424-428
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Quack I, Vonend O, Sellin L, Stegbauer J, Dekomien G, Rump LC. A tale of two patients with Mendelian hypertension. Hypertension 2008; 51 (03) 609-614
    CrossrefPubMedGoogle Scholar
  • 9 Vonend O, Altenhenne C, Büchner NJ, Dekomien G, Maser-Gluth C, Weiner SM, Sellin L, Hofebauer S, Epplen JT, Rump LC. A German family with glucocorticoid-remediable aldosteronism. Nephrol Dial Transplant 2007; 22 (04) 1123-1130
    CrossrefPubMedGoogle Scholar
  • 10 Fischer E, Beuschlein F, Reincke M. Diagnosis of endocrinological hypertension: when to screen, and by which method?. Dtsch Med Wochenschr 2011; 136 (11) 537-540
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S. Participants of German Conn’s Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2009; 94 (03) 869-875
    Google Scholar
  • 12 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM. Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93 (09) 3266-3281
    Google Scholar
  • 13 Betz MJ, Degenhart C, Fischer E, Pallauf A, Brand V, Linsenmaier U, Beuschlein F, Bidlingmaier M, Reincke M. Adrenal Vein Sampling using Rapid Cortisol Assays in Primary Aldosteronism is useful in Centers with Low Success Rates. Eur J Endocrinol 2011; 165 (02) 301-306
    Google Scholar
  • 14 Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 1998; 83 (11) 3996-4001
    CrossrefPubMedGoogle Scholar
  • 15 Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun 1995; 207 (02) 565-571
    CrossrefPubMedGoogle Scholar
  • 16 Stowasser M, Gunasekera TG, Gordon RD. Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol 2001; 28 (12) 1087-1090
    CrossrefPubMedGoogle Scholar
  • 17 Holinski-Feder E, Muller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J, Ballhausen W, Gross M, Baldwin-Jedele K, Jungck M, Mangold E, Vogelsang H, Schackert HK, Lohsea P, Murken J, Meitinger T. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Meth 2001; 47 (1–2) 21-32
    CrossrefPubMedGoogle Scholar
  • 18 Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F. PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1 125 hypertensive patients. J Am Coll Cardiol 2006; 48 (11) 2293-2300
    Google Scholar
  • 19 Aglony M, Martinez-Aguayo A, Carvajal CA, Campino C, García H, Bancalari R, Bolte L, Avalos C, Loureiro C, Trejo P, Brinkmann K, Giadrosich V, Mericq C, Rocha A, Avila A, Perez V, Inostroza A, Fardella CE. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension 2011; 57 (19) 1117-1121
    CrossrefPubMedGoogle Scholar
  • 20 Stowasser M, Gordon RD. Familial hyperaldosteronism. J Steroid Biochem Mol Biol 2001; 78 (03) 215-229
    CrossrefPubMedGoogle Scholar
  • 21 Stowasser M, Pimenta E. Familial or genetic primary aldosteronism and Gordon syndrome. Endocrinol Metab Clin North Am 2011; 40 (02) 343-368
    CrossrefPubMedGoogle Scholar
  • 22 Mulatero P, Tizzani D, Viola A. Prevalence and Characteristics of Familial Hyperaldosteronism: The PATOGEN Study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 2011; 58 (05) 797-803
    Google Scholar
  • 23 Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 2000; 37 (11) 831-835
    Google Scholar
  • 24 Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36 (11) 801-818
    PubMedGoogle Scholar
  • 25 Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergård P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368 (6468) 258-261
    CrossrefPubMedGoogle Scholar
  • 26 Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75 (05) 1027-1038
    CrossrefPubMedGoogle Scholar
  • 27 Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17 (03) 271-272
    CrossrefPubMedGoogle Scholar
  • 28 Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371 (6492) 75-80
    CrossrefPubMedGoogle Scholar
  • 29 Hopkins TG, Salem V, El-Gayar H, Palazzo FF, Meeran K, Tan T. Familial adenomatous polyposis and hypertension. Lancet 2010; 375 (9727) 1752
    CrossrefPubMedGoogle Scholar